Ginkgo Bioworks, XpresSpa Get Contract to Expand CDC’s SARS-CoV-2 Surveillance Program In US Airports








MT Newswires 2022

All news about GINKGO BIOWORKS HOLDINGS, INC.

Analyst Recommendations on GINKGO BIOWORKS HOLDINGS, INC.

Sales 2022 385 M

Net income 2022 -993 M

Net cash 2022 1 573 M

P/E ratio 2022 -5,63x
Yield 2022
Capitalization 6 470 M
6 470 M
EV / Sales 2022 12,7x
EV / Sales 2023 12,4x
Nbr of Employees 641
Free-Float 53,5%

Chart GINKGO BIOWORKS HOLDINGS, INC.



Duration :


Period :




Ginkgo Bioworks Holdings, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends GINKGO BIOWORKS HOLDINGS, INC.

Short Term Mid-Term Long Term
Trends Bullish Neutral Bearish



Income Statement Evolution

Sell

Buy

Mean consensus BUY
Number of Analysts 8
Last Close Price 3,63 $
Average target price 7,41 $
Spread / Average Target 104%




Source link

Ozinize
Logo
Shopping cart